S E R I L I N K

ABOUT US

Relying on well-known professors from the University of Hong Kong, it brings together professionals in chemistry, biology, and computer science. Serilink Biotechnology Co., Ltd. (Serilink) focuses on the biomedical industry, makes full use of the advantages of talents, capital, and policies in the Greater Bay Area, and through the combination of technology, capital, and market, is committed to applying innovative technology to practice and creating The leading conjugation technology platform promotes the research and development process of biomedicine (ADC/PDC/ARC and other drugs) in the Greater Bay Area, and catches up with the wave of vigorous development of biomedicine with counterparts in the Greater Bay Area.

Contact us

+852 37957271

inquiry@serilinkhk.com

615, 17W, Hong Kong Science Park, Sha Tin, Hong Kong

Serilink participated in BIO 2024 in the US

Serilink was recommended to represent Hong Kong's biotech startups, join 15 other outstanding park companies the Hong Kong Science and Technology Parks Corporation to participate in the BIO2024 exhibition held from June 3rd to 6th in San Diego, USA. Over the four-day exhibition, Dr. Lu Qing, CEO, and Dr. Hoi Yee Chow, COO, engaged in dialogues and exchanged information with many industry peers and leaders, discovering potential collaboration opportunities, and gained a lot of insights. The US BIO exhibition is the largest biotech exhibition globally, gathering over 18,000 biomedical industry leaders worldwide, with participants ranging from startups to multinational pharmaceutical companies, providing opportunities for global biomedical ecosystems to communicate and collaborate.

202407230101.png

202407230102.png